BIOFORCE NANOSCIENCES HLD vs. NVIDIA Corporation
BIOFORCE NANOSCIENCES HLD and NVIDIA Corporation are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| BFNH | NVDA | |
|---|---|---|
| Market Cap | — | $5.20 trillion |
| Revenue (TTM) | — | $253.49 billion |
| Net Income (TTM) | — | $159.61 billion |
BFNH and NVDA split the size & scale factors evenly.
Valuation
| BFNH | NVDA | |
|---|---|---|
| P/E Ratio | — | 32.19 |
| Price / Book | — | 26.61 |
| Price / Sales | — | 20.52 |
BFNH and NVDA split the valuation factors evenly.
Profitability
| BFNH | NVDA | |
|---|---|---|
| Net Margin | — | 62.97% |
| Return on Equity | — | 81.65% |
BFNH and NVDA split the profitability factors evenly.
Dividend
| BFNH | NVDA | |
|---|---|---|
| Dividend Yield | — | 0.48% |
| Payout Ratio | — | 15.31 |
BFNH and NVDA split the dividend factors evenly.
Risk & Sentiment
| BFNH | NVDA | |
|---|---|---|
| Short Interest | — | 0.07% |
BFNH and NVDA split the risk & sentiment factors evenly.
Dig deeper: BFNH overview, BFNH financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.